Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $19.8 Million - $22.4 Million
270,000 New
270,000 $21.9 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $9.48 Million - $10.2 Million
140,000 New
140,000 $9.78 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $7.78 Million - $9.96 Million
-124,200 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $29 Million - $32 Million
-471,400 Reduced 79.15%
124,200 $8.07 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $5.28 Million - $5.83 Million
84,500 Added 16.53%
595,600 $37.7 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $31.6 Million - $35.5 Million
511,100 New
511,100 $34.5 Million
Q1 2019

May 08, 2019

SELL
$62.53 - $70.05 $11.7 Million - $13.1 Million
-186,800 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $3.24 Million - $4.23 Million
-53,500 Reduced 22.26%
186,800 $11.7 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $8.33 Million - $9.22 Million
116,800 Added 94.57%
240,300 $18.6 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $42.1 Million - $51.3 Million
-577,500 Reduced 82.38%
123,500 $9.31 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $50.5 Million - $59.9 Million
701,000
701,000 $56.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.